Aggressive non-Hodgkin’s lymphoma: improved prognosis with combination chemotherapy
New Drugs and Disease Management
- 10 Downloads
KeywordsBleomycin Fenofibrate Fluvastatin International Prognostic Index Calcium Folinate
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- 5.Montserrat E, Garcia-Conde J, Vinolas N, et al. ProMACE-CytaBOM vs CHOP in the treatment of unfavorable lymphomas: a randomized trial [abstract]. Blood 1991; 78: 127AGoogle Scholar
- 7.Fisher RI. CHOP is the current standard for the treatment of high risk patients with diffuse large cell lymphoma [abstract no. 036]. VIth International Conference on Malignant Lymphoma; 1996 Jun 5–8: Lugano. Ann Oncol 1996; 7 Suppl. 3: 12Google Scholar
- 14.Longo DL, Glatstein E, Duffey PL, et al. Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy. J Clin Oncol 1989; 9: 1295–302Google Scholar
- 15.Tondini C, Zanini M, Lombardi F, et al. Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin’s lymphomas. J Clin Oncol 1993; 4: 720–5Google Scholar
- 17.Miller TP, Dahlberg S, Cassady JR, et al. Three cycles of CHOP (3) plus radiotherapy (RT) is superior to eight cycles of CHOP (8) alone for localized intermediate and high grade non-Hodgkins lymphoma: a Southwest Oncology Study Group [abstract no. 1257]. Proceedings of the XXXIIth ASCO Meeting; 1996 May 18–21: PhiladelphiaGoogle Scholar
© Adis International Limited 1998